文献速递神经儿科影像MR

碳酸酐酶VA缺乏症的神经影像学表现:病例系列揭示潜在可逆性线粒体功能障碍的诊断与预后模式

Neuroimaging Findings in Carbonic Anhydrase VA Deficiency: A Case Series Highlighting Diagnostic and Prognostic Patterns in a Potentially Reversible Mitochondrial Dysfunction.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-01-05

本研究为5家大型中心合作的回顾性纵向研究,纳入9例经CA5A变异确诊的碳酸酐酶VA缺乏症患者,按标准化报告表回顾初诊及随访MRI。所有患者均有脑影像异常:预后良好组呈尿素循环障碍样模式,选择性累及岛叶/岛周皮层及皮层下区域、外侧裂/外侧裂周及中央前后回皮层;预后不良组上述区域受累更广泛,并扩展至丘脑、基底节和脑干。

要点

  • 碳酸酐酶VA缺乏症患者脑MRI均可出现异常,常呈提示尿素循环障碍的选择性皮层/皮层下受累模式。
  • 预后良好组累及岛叶/岛周、外侧裂/外侧裂周及中央前后回皮层;预后不良组范围更广,扩展至丘脑、基底节和脑干。
  • MRI有助于早期诊断,并可能作为预后标志物影响临床决策、管理与随访策略。

核心结论

  • MRI在碳酸酐酶VA缺乏症早期诊断中起关键作用,因脑异常可预期且常呈提示尿素循环障碍的特征;神经影像可能作为有价值的预后标志物,直接影响临床决策、管理和随访策略。

研究设计与样本

  • 回顾性纵向研究,在5家大型中心纳入9例经CA5A变异确诊的碳酸酐酶VA缺乏症患者,按标准化报告表对初诊和随访MRI进行定性评估,参考标准为CA5A变异确认。

关键影像表现/征象

  • 预后良好组影像呈尿素循环障碍样模式,选择性累及岛叶/岛周区域、外侧裂/外侧裂周及中央前后回皮层的皮层和皮层下区域。
  • 预后不良组上述区域受累更广泛,并扩展至丘脑、基底节和脑干。
  • 3例有随访MRI:2例(预后良好组)脑异常接近完全消退,1例(预后不良组)显示相对广泛的慢性胶质增生改变。

诊断标准与关键数值

  • 预后良好定义为无显著神经功能损害,5例(55.5%)达到;4例(44.4%)存在中重度长期神经功能损害。
  • 症状发作中位年龄3天(四分位距2.5-48.5天),症状发作至脑MRI的中位间隔7天。
  • 7例(77%)迄今经历一次代谢危象;9例中6例为女孩。

临床应用与阅片要点

  • 碳酸酐酶VA缺乏症患者脑MRI异常可预期,阅片时应关注岛叶/岛周、外侧裂/外侧裂周及中央前后回皮层的选择性受累模式。
  • 若上述区域受累广泛并扩展至丘脑、基底节和脑干,可能提示预后不良。
  • 随访MRI可显示脑异常接近完全消退或慢性胶质增生改变,可用于随访评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Imaging characteristics of the secondary urea cycle disorder caused by carbonic anhydrase VA (CA-VA) deficiency remain poorly understood. This study aimed to evaluate the neuroimaging features associated with CA-VA deficiency through a collaborative multicenter investigation.

MATERIALS AND METHODS: A retrospective, longitudinal study with confirmed CA5A variants at 5 large centers was performed. MR studies were qualitatively reviewed according to a standardized reporting form at initial and follow-up MRI.

RESULTS: A total of 9 patients with CA-VA deficiency were included, 6 of whom were girls. The median age at symptom onset was 3 days (interquartile range: 2.5-48.5 days), and the median interval between symptom onset and brain MRI was 7 days. Seven patients (77%) had experienced a single metabolic crisis so far. A favorable clinical outcome, defined as the absence of notable neurologic impairment was observed in 5 patients (55.5%), while 4 (44.4%) exhibited moderate to severe neurologic long-term impairment. All patients demonstrated brain imaging abnormalities. In the favorable-outcome group (FOG), imaging findings demonstrated a urea cycle disorder (UCD)-like pattern, with selective involvement of the cortical and juxtacortical regions of the insular/peri-insular area, the Sylvian/peri-Sylvian fissures, and the perirolandic cortex. In contrast, the unfavorable-outcome group (UOG) exhibited either more extensive involvement of the aforementioned regions, extending to the thalamus, basal ganglia, and brainstem. Follow-up MRI was available for 3 patients; 2 showed near-complete resolution of brain abnormalities (FOG), while 1 displayed relatively extensive chronic gliotic changes (UOG).

CONCLUSIONS: MRI plays a key role in the early diagnosis of CA-VA deficiency, because brain abnormalities are expected and often exhibit features suggestive of an underlying UCD. Furthermore, neuroimaging may serve as a valuable prognostic marker, directly impacting clinical decision-making, management, and follow-up strategies.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Fragoso DC, Al-Ajmi E, Cardenas AM, et al. Neuroimaging Findings in Carbonic Anhydrase VA Deficiency: A Case Series Highlighting Diagnostic and Prognostic Patterns in a Potentially Reversible Mitochondrial Dysfunction. AJNR Am J Neuroradiol. 2026. PMID: 41022560. doi:10.3174/ajnr.A8948

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。